Tag: olaparib abiraterone approval

Home / olaparib abiraterone approval

Categories

Olaparib with abiraterone and prednisone (or prednisolone) is approved by FDA for BRCA-mutated metastatic castration-resistant prostate cancer

July 2023: The Food and Drug Administration (FDA) approved olaparib (Lynparza, AstraZeneca Pharmaceuticals LP) with abiraterone and prednisone (or prednisolone) for adults with deleterious or suspecte...
olaparib-abiraterone-approval

Scan the code